Joseph Power

Community-engagement-alumni-profile-Joe-Power

Joseph Power leads an interesting career
in marketing and pharmaceutical sales.

BBA, 2000
Brand Manager Lucentis
Novartis Pharmaceuticals Canada Inc.
Dorval, QC

Memorial’s bachelor of business administration (BBA) degree has proven the perfect foundation for Joseph Power's career in pharmaceutical sales and marketing - a career that includes increasingly senior roles and responsibilities and new opportunities on the horizon.

Not long after graduating with a BBA in October 2000, Joseph Power moved to Alberta and was scouted by Novartis Pharmaceuticals Canada Inc., a leading global research-based company of innovative prescription medications.

Mr. Power began as a pharmaceutical sales representative and soon acquired the Canadian certified physician executive (CCPE) designation.

After three years in sales, Mr. Power switched his focus to become a marketing intelligence analyst for Novartis Oncology Canada. He was promoted to brand manager for the company’s ophthalmic division, where he managed a large portfolio of products and was responsible for developing five-year brand plans, managing forecasts (revenue and supply), and developing advertising, promotions and promotional material for the ophthalmic sales force.

Mr. Power went on to become the associate sales director of Western Canada for Novartis's ophthalmic business franchise and the commercial excellence manager for Novartis Oncology Canada. He is currently the brand manager, Lucentis, for Novartis Pharmaceuticals, Canada.

Mr. Power is proud to be an alumnus of Memorial and often visits the Faculty of Business Administration when he returns to visit family in St. John’s.

A devoted supporter of cancer research, he’s an active member for the Novartis team in Ride for the Cure and has completed five 600-kilometre bicycle rides from Toronto to Montreal from 2007-2011.

Mr. Power and his Novartis Canada colleagues raised over $152,000 in one year for the event and to date, Novartis riders have raised nearly $700,000 for the Canadian Breast Cancer Foundation.